TheraCryf PLC (TCF)

Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.70p

Buy

0.80p

arrow-up0.00p (+0.00%)

Prices updated at 17 May 2024, 12:36 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Evgen Pharma PLC is a clinical stage drug development company focused on cancer and neurological disease. Its pipeline is based on Sulforadex technology which includes synthetic and stabilized analogues of sulforaphane.
FTSE All-Share
arrow-down-0.23%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
0.75
triangle-d
arrow-up
0.00 (+0.00%)
triangle-d
Today open
0.75
triangle-d
arrow-up
0.00 (+0.00%)
triangle-d
Today, 12:36:00 BST
0.75
triangle-d
0.72p - 0.72p
4.00p - 0.70p
-
3.21m
-
75,000
26,775
0.81
766,225.98
1.98
274.89m
GB00BSVYN304
-0.01
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.